Search - tctmd.com

Displaying 101 - 120 of 318

Sort: Relevancy | Date

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

Advertisement

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

November 2022 News Roundup

New Biomarker-Based Risk Score Performs Well in ACS

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Polypill Bests Usual Care in Patients With Recent MI: SECURE

What’s Going to Be Hot at ESC 2022?

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

June 2022 News Roundup

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

April 2022 News Roundup

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content